Guy C. Le Breton - Publications

Affiliations: 
University of Illinois at Chicago, Health Sciences Center, Chicago, IL 60612, United States 
Area:
Cell Biology, Pharmacology, Neuroscience Biology

35/90 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Srinivasan S, Schiemer J, Zhang X, Chishti AH, Le Breton GC. Gα13 Switch Region 2 Binds to the Talin Head Domain and Activates αIIbβ3 Integrin in Human Platelets. The Journal of Biological Chemistry. PMID 26292217 DOI: 10.1074/jbc.M115.650978  0.34
2011 Gussin HA, Khasawneh FT, Xie A, Feng F, Memic A, Qian H, Le Breton GC, Pepperberg DR. Subunit-specific polyclonal antibody targeting human ρ1 GABA(C) receptor. Experimental Eye Research. 93: 59-64. PMID 21536029 DOI: 10.1016/J.Exer.2011.04.009  0.62
2009 Srinivasan S, Mir F, Huang JS, Khasawneh FT, Lam SC, Le Breton GC. The P2Y12 antagonists, 2-methylthioadenosine 5'-monophosphate triethylammonium salt and cangrelor (ARC69931MX), can inhibit human platelet aggregation through a Gi-independent increase in cAMP levels. The Journal of Biological Chemistry. 284: 16108-17. PMID 19346255 DOI: 10.1074/Jbc.M809780200  0.742
2008 Mir F, Le Breton GC. A novel nuclear signaling pathway for thromboxane A2 receptors in oligodendrocytes: evidence for signaling compartmentalization during differentiation. Molecular and Cellular Biology. 28: 6329-41. PMID 18710937 DOI: 10.1128/MCB.00482-08  0.318
2008 Khasawneh FT, Huang JS, Mir F, Srinivasan S, Tiruppathi C, Le Breton GC. Characterization of isoprostane signaling: evidence for a unique coordination profile of 8-iso-PGF(2alpha) with the thromboxane A(2) receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets. Biochemical Pharmacology. 75: 2301-15. PMID 18455148 DOI: 10.1016/J.Bcp.2008.03.014  0.673
2007 Huang JS, Dong L, Kozasa T, Le Breton GC. Signaling through G(alpha)13 switch region I is essential for protease-activated receptor 1-mediated human platelet shape change, aggregation, and secretion. The Journal of Biological Chemistry. 282: 10210-22. PMID 17298951 DOI: 10.1074/Jbc.M605678200  0.37
2006 Ramamurthy S, Mir F, Gould RM, Le Breton GC. Characterization of thromboxane A2 receptor signaling in developing rat oligodendrocytes: nuclear receptor localization and stimulation of myelin basic protein expression. Journal of Neuroscience Research. 84: 1402-14. PMID 16998891 DOI: 10.1002/Jnr.21061  0.772
2006 Khasawneh FT, Huang JS, Turek JW, Le Breton GC. Differential mapping of the amino acids mediating agonist and antagonist coordination with the human thromboxane A2 receptor protein. The Journal of Biological Chemistry. 281: 26951-65. PMID 16837469 DOI: 10.1182/Blood.V106.11.3571.3571  0.729
2006 Huang JS, Dong L, Le Breton GC. Mass-dependent signaling between G protein coupled receptors. Cellular Signalling. 18: 564-76. PMID 16125366 DOI: 10.1016/j.cellsig.2005.06.011  0.461
2005 Lin X, Ramamurthy SK, Le Breton GC. Thromboxane A receptor-mediated cell proliferation, survival and gene expression in oligodendrocytes. Journal of Neurochemistry. 93: 257-68. PMID 15816849 DOI: 10.1111/j.1471-4159.2004.02969.x  0.777
2004 Huang JS, Ramamurthy SK, Lin X, Le Breton GC. Cell signalling through thromboxane A2 receptors. Cellular Signalling. 16: 521-33. PMID 14751539 DOI: 10.1016/j.cellsig.2003.10.008  0.799
2003 Manganello JM, Huang JS, Kozasa T, Voyno-Yasenetskaya TA, Le Breton GC. Protein kinase A-mediated phosphorylation of the Galpha13 switch I region alters the Galphabetagamma13-G protein-coupled receptor complex and inhibits Rho activation. The Journal of Biological Chemistry. 278: 124-30. PMID 12399457 DOI: 10.1074/Jbc.M209219200  0.749
2002 Turek JW, Halmos T, Sullivan NL, Antonakis K, Le Breton GC. Mapping of a ligand-binding site for the human thromboxane A2 receptor protein. The Journal of Biological Chemistry. 277: 16791-7. PMID 11877412 DOI: 10.1074/Jbc.M105872200  0.683
2001 Muja N, Blackman SC, Le Breton GC, DeVries GH. Identification and functional characterization of thromboxane A2 receptors in Schwann cells. Journal of Neurochemistry. 78: 446-56. PMID 11483647 DOI: 10.1046/J.1471-4159.2001.00378.X  0.778
2000 Djellas Y, Antonakis K, Le Breton GC. Shifts in the affinity distribution of one class of seven-transmembrane receptors by activation of a separate class of seven-transmembrane receptors Biochemical Pharmacology. 59: 1521-1529. PMID 10799648 DOI: 10.1016/S0006-2952(00)00296-3  0.49
1999 Halmos T, Turek JW, Le Breton GC, Antonakis K. Synthesis and biological characterization of sqbazide, a novel biotinylated photoaffinity probe for the study of the human platelet thromboxane A2 receptor. Bioorganic & Medicinal Chemistry Letters. 9: 2963-8. PMID 10571156 DOI: 10.1016/S0960-894X(99)00511-9  0.672
1999 Manganello JM, Djellas Y, Borg C, Antonakis K, Le Breton GC. Cyclic AMP-dependent phosphorylation of thromboxane A(2) receptor-associated Galpha(13). The Journal of Biological Chemistry. 274: 28003-10. PMID 10488151 DOI: 10.1074/jbc.274.39.28003  0.774
1999 Blackman SC, Borg C, Yeomans DC, Le Breton GC. Assessment of cellular localization of the thromboxane A2 receptor by immunocytochemistry. Methods in Molecular Biology (Clifton, N.J.). 120: 145-71. PMID 10343316 DOI: 10.1385/1-59259-263-5:145  0.736
1999 Djellas Y, Manganello JM, Antonakis K, Le Breton GC. Identification of Galpha13 as one of the G-proteins that couple to human platelet thromboxane A2 receptors. The Journal of Biological Chemistry. 274: 14325-30. PMID 10318854 DOI: 10.1074/Jbc.274.20.14325  0.773
1998 Djellas Y, Antonakis K, Le Breton GC. A molecular mechanism for signaling between seven-transmembrane receptors: Evidence for a redistribution of G proteins Proceedings of the National Academy of Sciences of the United States of America. 95: 10944-10948. PMID 9724809 DOI: 10.1073/pnas.95.18.10944  0.517
1998 Blackman SC, Dawson G, Antonakis K, Le Breton GC. The identification and characterization of oligodendrocyte thromboxane A2 receptors. The Journal of Biological Chemistry. 273: 475-83. PMID 9417106 DOI: 10.1074/Jbc.273.1.475  0.777
1996 Nakamura F, Minshall RD, Le Breton GC, Rabito SF. Thromboxane A2 mediates the stimulation of inositol 1,4,5- trisphosphate production and intracellular calcium mobilization by bradykinin in neonatal rat ventricular cardiomyocytes Hypertension. 28: 444-449. PMID 8794831  0.335
1996 Komiotis D, Wencel-Drake JD, Dieter JP, Lim CT, Le Breton GC. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe Biochemical Pharmacology. 52: 763-770. PMID 8765474 DOI: 10.1016/0006-2952(96)00359-0  0.34
1996 Bresnahan BA, Le Breton GC, Lianos EA. Localization of authentic thromboxane A2/prostaglandin H2 receptor in the rat kidney. Kidney International. 49: 1207-13. PMID 8731083 DOI: 10.1038/ki.1996.174  0.406
1994 Borg C, Lim CT, Yeomans DC, Dieter JP, Komiotis D, Anderson EG, Le Breton GC. Purification of rat brain, rabbit aorta, and human platelet thromboxane A2/prostaglandin H2 receptors by immunoaffinity chromatography employing anti-peptide and anti-receptor antibodies. The Journal of Biological Chemistry. 269: 6109-16. PMID 8119956  0.421
1993 Knezevic I, Borg C, Le Breton GC. Identification of Gq as one of the G-proteins which copurify with human platelet thromboxane A2/prostaglandin H2 receptors Journal of Biological Chemistry. 268: 26011-26017. PMID 8245033  0.502
1993 Borg C, Lam SCT, Dieter JP, Lim CT, Komiotis D, Venton DL, le Breton GC. Anti-peptide antibodies against the human blood platelet thromboxane A2/prostaglandin H2 receptor. Production, purification and characterization Biochemical Pharmacology. 45: 2071-2078. PMID 7685602 DOI: 10.1016/0006-2952(93)90018-R  0.362
1992 Sun-Ok K, Chang T. L, Lam SCT, Hall SE, Komiotis D, Venton DL, Le Breton GC. Purification of the human blood platelet thromboxane A2/prostaglandin H2 receptor protein Biochemical Pharmacology. 43: 313-322. PMID 1739420 DOI: 10.1016/0006-2952(92)90294-S  0.444
1990 Le Breton GC, Lim CT, Vaidya CM, Venton DL. Thromboxane A2/prostaglandin H2 receptor antagonists Methods in Enzymology. 187: 406-414. PMID 2146463 DOI: 10.1016/0076-6879(90)87047-7  0.445
1989 Swann PG, Venton DL, Le Breton GC. Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets Febs Letters. 243: 244-246. PMID 2537230 DOI: 10.1016/0014-5793(89)80137-1  0.347
1987 Arora SK, Kattelman EJ, Lim CT, Le Breton GC, Venton DL. Preparation and biological evaluation of a potential photoaffinity label for the prostaglandin H2/thromboxane A2 receptor Journal of Medicinal Chemistry. 30: 918-924. PMID 2952799 DOI: 10.1021/Jm00388A029  0.357
1987 Kattelman EJ, Arora SK, Lim CT, Venton DL, Le Breton GC. A photoaffinity label for the thromboxane A2/prostaglandin H2 receptor in human blood platelets Febs Letters. 213: 179-183. PMID 2951273 DOI: 10.1016/0014-5793(87)81487-4  0.336
1984 Le Breton GC, Hung SC, Ghali NI, Venton DL. 2-(6-carboxyhexyl)cyclopentanone hexylhydrazone: A potent inhibitor of the blood platelet cyclo-oxygenase Prostaglandins. 27: 543-551. PMID 6427851 DOI: 10.1016/0090-6980(84)90090-X  0.327
1984 Parise LV, Venton DL, Le Breton GC. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction Journal of Pharmacology and Experimental Therapeutics. 228: 240-244. PMID 6319669  0.338
1980 Le Breton GC, Venton DL. Thromboxane A2 receptor antagonism selectively reverses platelet aggregation Advances in Prostaglandin and Thromboxane Research. 6: 497-503. PMID 7386283  0.335
Low-probability matches (unlikely to be authored by this person)
2012 Wieschhaus AJ, Le Breton GC, Chishti AH. Headpiece domain of dematin regulates calcium mobilization and signaling in platelets. The Journal of Biological Chemistry. 287: 41218-31. PMID 23060452 DOI: 10.1074/Jbc.M112.364679  0.297
1984 Ghali NI, Kattelman EJ, Hung SC, Schnorf KE, Le Breton GC, Venton DL. Synthesis of [17,18-3H]trans-13-azaprostanoic acid. A labeled probe for the PGH2/TXA2 receptor Prostaglandins. 27: 865-876. PMID 6091182 DOI: 10.1016/S0090-6980(84)80006-4  0.296
1985 Brace LD, Venton DL, Le Breton GC. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets The American Journal of Physiology. 249. PMID 2409821 DOI: 10.1152/Ajpheart.1985.249.1.H8  0.28
2016 Schiemer J, Bohm A, Lin L, Merrill-Skoloff G, Flaumenhaft R, Huang JS, Le Breton GC, Chishti AH. Galpha13 Switch Region 2 Relieves Talin Autoinhibition to activate alphaIIbbeta3 Integrin. The Journal of Biological Chemistry. PMID 27803165 DOI: 10.1074/Jbc.M116.747279  0.279
1982 Hung SC, Ghali NI, Venton DL, Le Breton GC. Prostaglandin F2α antagonizes thromboxane A2-induced human platelet aggregation Prostaglandins. 24: 195-206. PMID 6293001 DOI: 10.1016/0090-6980(82)90145-9  0.261
1987 Hettasch JM, Le Breton GC. Modulation of Ca2+ fluxes in isolated platelet vesicles: effects of cAMP-dependent protein kinase and protein kinase inhibitor on Ca2+ sequestration and release Bba - Molecular Cell Research. 931: 49-58. PMID 2820511 DOI: 10.1016/0167-4889(87)90049-8  0.26
1979 Le Breton GC, Venton DL, Enke SE, Halushka PV. 13-Azaprostanoic acid: A specific antagonist of the human blood platelet thromboxane/endoperoxide receptor Proceedings of the National Academy of Sciences of the United States of America. 76: 4097-4101. PMID 291066 DOI: 10.1073/Pnas.76.8.4097  0.26
1986 Kattelman EJ, Venton DL, Le Breton GC. Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548) Thrombosis Research. 41: 471-481. PMID 3008368 DOI: 10.1016/0049-3848(86)91692-0  0.251
1982 Parise LV, Venton DL, Le Breton GC. Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP Journal of Pharmacology and Experimental Therapeutics. 222: 276-281. PMID 7086705  0.25
1982 Parise LV, Venton DL, Le Breton GC. Prostacyclin potentiates 13-azaprostanoic acid-induced platelet deaggregation Thrombosis Research. 28: 721-730. PMID 6301090 DOI: 10.1016/0049-3848(82)90097-4  0.249
1992 Komiotis D, Lim CT, Dieter JP, Le Breton GC, Venton DL. PgH2 analogs as potential antiplatelet derivatives Journal of Medicinal Chemistry. 35: 3033-3039. PMID 1501231 DOI: 10.1021/Jm00094A017  0.248
1992 Parent CA, Lagarde M, Venton DL, Le Breton GC. Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes Journal of Biological Chemistry. 267: 6541-6547. PMID 1532390  0.241
1983 Rybicki JP, Le Breton GC. Prostaglandin H2 directly lowers human platelet cAMP levels Thrombosis Research. 30: 407-414. PMID 6310815 DOI: 10.1016/0049-3848(83)90174-3  0.233
2011 Xie A, Yan J, Yue L, Feng F, Mir F, Abdel-Halim H, Chebib M, Le Breton GC, Standaert RF, Qian H, Pepperberg DR. 2-Aminoethyl methylphosphonate, a potent and rapidly acting antagonist of GABA(A)-ρ1 receptors. Molecular Pharmacology. 80: 965-78. PMID 21810922 DOI: 10.1124/Mol.111.071225  0.233
1983 Hung SC, Ghali NI, Venton DL, Le Breton GC. Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes Bba - Biomembranes. 728: 171-178. PMID 6219702 DOI: 10.1016/0005-2736(83)90468-6  0.232
2003 Li Z, Zhang G, Le Breton GC, Gao X, Malik AB, Du X. Two waves of platelet secretion induced by thromboxane A2 receptor and a critical role for phosphoinositide 3-kinases. The Journal of Biological Chemistry. 278: 30725-31. PMID 12796499 DOI: 10.1074/jbc.M301838200  0.23
1985 Brace LD, Venton DL, Le Breton GC. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets The American Journal of Physiology. 249. PMID 3925795 DOI: 10.1152/Ajpheart.1985.249.1.H1  0.226
1984 Le Breton GC, Lipowski JP, Feinberg H. Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo Journal of Pharmacology and Experimental Therapeutics. 229: 80-84. PMID 6423815  0.223
1990 Swann PG, Parent CA, Croset M, Fonlupt P, Lagarde M, Venton DL, Le Breton GC. Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and Function Journal of Biological Chemistry. 265: 21692-21697. PMID 2147687  0.22
1982 Hung SC, Ghali NI, Venton DL, Le Breton GC. Prostaglandin F(2α) antagonized thromboxane A2-induced human platelet aggregation Prostaglandins. 24: 196-206.  0.219
1981 Wu KK, Le Breton GC, Tai HH, Chen YC. Abnormal platelet response to thromboxane A2 Journal of Clinical Investigation. 67: 1801-1804. PMID 6263954  0.213
1992 Knezevic I, Dieter JP, Le Breton GC. Mechanism of inositol 1,4,5-trisphosphate-induced aggregation in saponin- permeabilized platelets Journal of Pharmacology and Experimental Therapeutics. 260: 947-955. PMID 1545407  0.212
2012 Qian F, Le Breton GC, Chen J, Deng J, Christman JW, Wu D, Ye RD. Role for the guanine nucleotide exchange factor phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchanger 1 in platelet secretion and aggregation. Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 768-77. PMID 22207728 DOI: 10.1161/Atvbaha.111.243675  0.206
1991 Lam SCT, Dieter JP, Strebel LC, Taylor TM, Muscolino G, Feinberg H, Le Breton GC. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents Journal of Pharmacology and Experimental Therapeutics. 259: 1371-1378. PMID 1762085  0.189
1979 Venton DL, Enke SE, Le Breton GC. Azaprostanoic acid derivatives. Inhibitors of arachidonic acid induced Platelet aggregation Journal of Medicinal Chemistry. 22: 824-830. PMID 109614 DOI: 10.1002/Chin.197951337  0.189
1982 Hung SC, Ghali N, Venton DL, Le Breton GC. Specific binding of 13-azaprostanoic acid to human platelet membranes Federation Proceedings. 41.  0.186
1983 Ghali NI, Venton DL, Hung SC, Le Breton GC. 2-(6-Carboxyhexyl)cyclopentanone hexylhydrazone. A potent and time-dependent inhibitor of platelet aggregation Journal of Medicinal Chemistry. 26: 1056-1060. PMID 6408259 DOI: 10.1002/Chin.198348154  0.183
1980 Owen NE, Feinberg H, Le Breton GC. Epinephrine induces Ca2+ uptake in human blood platelets American Journal of Physiology - Heart and Circulatory Physiology. 8.  0.181
1981 Parise LV, Venton DL, Le Breton GC. Arachidonic acid and the prostaglandin endoperoxide analog (U46619) directly stimulate human platelet shape change Federation Proceedings. 40.  0.177
1978 Owen NE, Le Breton GC. Potentiation of human platelet aggregation by epinephrine or ADP: A calcium mediated process Circulation. 58.  0.174
1981 Owen NE, Le Breton GC. Ca2+ mobilization in blood platelets as visualized by chlortetracycline fluorescence The American Journal of Physiology. 241. PMID 6274207  0.174
1981 Owen NE, Le Breton GC. Ca(2+) mobilization in blood platelets as visualized by chlortetracycline fluorescence American Journal of Physiology - Heart and Circulatory Physiology. 10: 613-619.  0.174
1976 Le Breton GC, Dinerstein RJ, Roth LJ, Feinberg H. Direct evidence for intracellular divalent cation redistribution associated with platelet shape change Biochemical and Biophysical Research Communications. 71: 362-370. PMID 786285 DOI: 10.1016/0006-291X(76)90291-6  0.16
1980 Sandler WC, Le Breton GC, Feinberg H. Movement of sodium into human platelets Biochimica Et Biophysica Acta. 600: 448-455. PMID 7407123  0.155
1977 Le Breton GC, Dinerstein RJ. Effect of the calcium antagonist TMB-6 on intracellular calcium redistribution associated with platelet shape change Thrombosis Research. 10: 521-523. PMID 854884 DOI: 10.1016/0049-3848(77)90161-X  0.154
1980 Owen NE, Le Breton GC. The involvement of calcium in epinephrine or ADP potentiation of human platelet aggregation Thrombosis Research. 17: 855-863. PMID 7404491 DOI: 10.1016/0049-3848(80)90250-9  0.153
1976 Le Breton GC, Sandler WC, Feinberg H. The effect of D2O and chlortetracycline on ADP-induced platelet shape change and aggregation Thrombosis Research. 8: 477-485. PMID 1273808 DOI: 10.1016/0049-3848(76)90225-5  0.15
1990 Jonathan LT, Gbeassor M, Che CT, Fong HHS, Farnsworth NR, Le Breton GC, Venton DL. Pseudosemiglabrin, a platelet aggregation inhibitor from Tephrosia semiglabra Journal of Natural Products. 53: 1572-1574. PMID 2089123 DOI: 10.1021/Np50072A029  0.148
1981 Rybicki JP, Venton DL, Le Breton GC. 13-Azaprostanoic acid or indomethacin inhibit TXA2/PGH2 stimulated release of calcium from isolated platelet vesicles Thrombosis and Haemostasis. 46.  0.146
1977 Feinberg H, Sandler WC, Scorer M, Le Breton GC, Grossman B, Born GV. Movement of sodium into human platelets induced by ADP. Biochimica Et Biophysica Acta. 470: 317-24. PMID 911831 DOI: 10.1016/0005-2736(77)90109-2  0.143
1983 Brace LD, Venton DL, Le Breton GC. Reversal of TXA2- and ADP-induced Ca2+ mobilization in intact human platelets Federation Proceedings. 42.  0.141
1981 Parise LV, Venton D, Le Breton GC. 13-Azaprostanoic acid potentiates prostacyclin-induced platelet deaggregation Thrombosis and Haemostasis. 46.  0.134
1983 Rybicki JP, Venton DL, Le Breton GC. The thromboxane antagonist, 13-azaprostanoic acid, inhibits arachidonic acid-induced Ca2+ release from isolated platelet membrane vesicles Biochimica Et Biophysica Acta (Bba)/Lipids and Lipid Metabolism. 751: 66-73. PMID 6830832 DOI: 10.1016/0005-2760(83)90257-6  0.113
1995 Astarie-Dequeker C, Pernollet MG, Le Breton G, Devynck MA. Endothelin-3 reduces Ca(2+)-uptake and Ca2+ content of platelet internal stores. Biochemical and Biophysical Research Communications. 210: 889-97. PMID 7763261 DOI: 10.1006/bbrc.1995.1741  0.11
1976 Le Breton GC, Sandler WC, Feinberg H. Effects of D2O and chlortetracycline on platelet shape change and aggregation Federation Proceedings. 35.  0.109
1996 Swann PG, Casanova RA, Desai A, Frauenhoff MM, Urbancic M, Slomczynska U, Hopfinger AJ, Le Breton GC, Venton DL. Nonspecific protease-catalyzed hydrolysis/synthesis of a mixture of peptides: product diversity and ligand amplification by a molecular trap. Biopolymers. 40: 617-25. PMID 9140201 DOI: 10.1002/(Sici)1097-0282(1996)40:6<617::Aid-Bip3>3.0.Co;2-Z  0.102
1987 Zaragoza R, Le Breton GC. Effect of single-dose aspirin on TXA2 and PGI2 cyclooxygenases in vivo Haemostasis. 17: 40-48. PMID 3110025  0.098
1984 Lipowski JP, Le Breton GC, Feinberg H. Evidence for the direct involvement of TXA 2/PGH 2 in thrombus formation (in vivo) at a site of vascular damage Federation Proceedings. 43.  0.097
1985 Le Breton GC, Jafar JJ, Menoni RM. Selective platelet deposition during focal cerebral ischemia in the cat Federation Proceedings. 44.  0.087
1990 Venton D, Le Breton G, Hall E. Preparation of prostaglandin H2: extended purification/analysis scheme. Methods in Enzymology. 187: 245-52. PMID 2233348 DOI: 10.1016/0076-6879(90)87029-3  0.061
1977 Le Breton GC, Hoffmann PC. Ubiquinone and cytochrome b in isolated rat heart Journal of Molecular and Cellular Cardiology. 9: 967-987. PMID 592416 DOI: 10.1016/S0022-2828(77)80050-3  0.058
1986 Cho BP, Chadha VK, Le Breton GC, Venton DL. Preparation of 9-hydroxy-14-azaprostanoic acids Journal of Organic Chemistry. 51: 4279-4284. DOI: 10.1021/Jo00372A032  0.039
1986 Arora SK, Cho BS, Chadha VK, Bauer AJ, Venton DL, Lim CT, Le Breton GC. 3‐[(Z)‐2‐t‐Butoxyethenyl]‐4‐hydroxy‐2(5H)‐furanone, an interesting byproduct obtained from reaction of 4‐t‐butoxy‐2‐butenoate with the alkoxide anion of methyl glycolate Journal of Heterocyclic Chemistry. 23: 963-964. DOI: 10.1002/Jhet.5570230362  0.035
1981 Ghali NI, Venton DL, Hung SC, Le Breton GC. A high-yielding synthesis of monoalkylhydrazines Journal of Organic Chemistry. 46: 5413-5414. DOI: 10.1021/Jo00339A035  0.026
2015 Abbas R, Carnet D, D'Athis P, Fiet C, Le Breton G, Romestaing M, Quantin C. [Comparison of British and French expatriate doctors' characteristics and motivations]. Revue D'éPidéMiologie Et De Santé Publique. 63: 21-8. PMID 25614374 DOI: 10.1016/J.Respe.2014.12.018  0.013
Hide low-probability matches.